Search results :

Tofacitinib

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2
Upper respiratory tract infection Upper respiratory tract infection 3.8% - 4.5% 3.3% x x
Headache Headache 3.4% - 4.3% 2.1% x x
Diarrhoea Diarrhoea 2.9% - 4% 2.3% x x
Nasopharyngitis Nasopharyngitis 2.8% - 3.8% 2.8% x x
Hypertension Hypertension 1.6% - 2.3% 1.1% x x
Abdominal pain Abdominal pain x x
Gastrointestinal pain Abdominal pain x x
Anaemia Anaemia x x
Arthralgia Arthralgia x x
Musculoskeletal discomfort Arthralgia x x
Mental disorder Mental disorder x x
Bone disorder Bone disorder x x
Breast cancer Breast cancer x x
Neoplasm malignant Neoplasm malignant x x
Cellulitis Cellulitis x x
Infection Infection x x
Cough Cough x x
Cyst Cyst x
Dehydration Dehydration x x
Dyspepsia Dyspepsia x x
Dyspnoea Dyspnoea x x
Dermatitis Rash x x
Rash Rash x x
Asthenia Fatigue x x
Fatigue Fatigue x x
Body temperature increased Body temperature increased x x
Gastritis Gastritis x x
Gastrointestinal disorder Gastrointestinal disorder x x
Herpes zoster Herpes zoster x x
Lymphoma Lymphoma x x
Non-Hodgkin's lymphoma Lymphoma x x
Lymphopenia Lymphopenia x
Mediastinal disorder Mediastinal disorder x x
Malignant melanoma Malignant melanoma x x
Melanoma skin x
Musculoskeletal pain Musculoskeletal pain x x
Nausea Nausea x x
Neoplasm Neoplasm x
Nervous system disorder Nervous system disorder x x
Neutropenia Neutropenia x x
Opportunistic infection Opportunistic infection x x
Paraesthesia Paraesthesia x x
Pneumonia Pneumonia x x
Polyp Polyp x
Pruritus Pruritus x x
Tendonitis Tendonitis x x
Tuberculosis Tuberculosis x x
Erythema Erythema x x
Urinary tract infection Urinary tract infection x x
Vomiting Vomiting x x
Oedema peripheral Oedema peripheral x x
Sinus congestion Sinus congestion x x
Joint swelling Joint swelling x x
Disseminated tuberculosis Disseminated tuberculosis x x
Malnutrition Malnutrition x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x
Hepatobiliary disease Hepatobiliary disease x x
Prostate cancer Prostate cancer x x
High density lipoprotein decreased Low density lipoprotein increased x x
Low density lipoprotein increased Low density lipoprotein increased x x
Blood creatinine increased Serum creatinine increased x x
Drug-induced liver injury Drug-induced liver injury x x
Insomnia Insomnia x x
Hepatic steatosis Hepatic steatosis x x
High density lipoprotein increased HDL cholesterol increased x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TOFACITINIB

Side effects:55
Source:FDA Structured Product Label

TOFACITINIB

Side effects:60
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label